Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Vyome Holdings Inc (HIND)

Vyome Holdings Inc (HIND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Vyome Holdings Inc Harvard Square One Mifflin Place Suite 400 Cambridge MA 02138 USA

https://vyometx.com Employees: 18 P: 973-832-8147

Sector:

Medical

Description:

Vyome Therapeutics Inc. is a clinical-stage healthcare company targeting immuno-inflammatory and rare diseases principally in the US. Vyome Therapeutics Inc., formerly known as ReShape Lifesciences Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 14,732
Enterprise Value, $K 14,752
Shares Outstanding, K 5,644
Float, K 3,783
% Float 67.02%
Short Interest, K 81
Short Float 1.44%
Days to Cover 3.11
Short Volume Ratio 0.41
% of Insider Shareholders 32.98%
% of Institutional Shareholders 22.06%

Financials:

Annual Sales, $ 8,010 K
Annual Net Income, $ -7,130 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -8,430 K
EBIT, $ -14,180 K
EBITDA, $ -14,050 K

Growth:

1-Year Return -98.98%
3-Year Return -99.99%
5-Year Return -100.00%
5-Year Revenue Growth 144.21%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -3.12 on 11/14/25
Next Earnings Date 04/03/26
Earnings Per Share ttm -125.20
EPS Growth vs. Prev Qtr 65.33%
EPS Growth vs. Prev Year 99.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 08/15/25

HIND Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -423.39%
Return-on-Assets % -166.02%
Profit Margin % -89.01%
Debt/Equity 0.00
Price/Sales 48.30
Price/Cash Flow N/A
Price/Book 2.39
Book Value/Share 1.07
Interest Coverage -0.35
60-Month Beta 1.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar